Disease modifying treatments and symptomatic drugs for cognitive impairment in multiple sclerosis: where do we stand?

Overview of attention for article published in Multiple Sclerosis and Demyelinating Disorders, June 2017

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (80th percentile)

Mentioned by

news: 1 news outlet

twitter: 1 X user

Citations

dimensions_citation: 12 Dimensions

Readers on

mendeley: 24 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 1 news story.

Νευροψυχολογικές διαταραχές και πολλαπλή σκλήρυνση

IatroNet, 04 Oct 2020

Η πολλαπλή σκλήρυνση είναι η πιο συχνή απομυελινωτική νόσος του Κεντρικού Νευρικού Συστήματος (ΚΝΣ) και επηρεάζει σε σημαντικό βα…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.